# Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

> **NCT03241147** · PHASE1 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 23 (actual)

## Conditions studied

- Renal Failure

## Interventions

- **DRUG:** Lu AF35700

## Key facts

- **NCT ID:** NCT03241147
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-25
- **Primary completion:** 2019-07-17
- **Final completion:** 2019-07-24
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** New data; the study was terminated based on new efficacy data
- **Last updated:** 2019-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03241147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03241147, "Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03241147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*